Mechanism of action of losartan
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action of Losartan
Angiotensin II Type 1 Receptor Antagonism
Losartan is primarily known as an angiotensin II type 1 (AT1) receptor antagonist. By selectively blocking the AT1 receptor, losartan prevents angiotensin II from binding to these receptors, which in turn inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This mechanism is crucial for its role in managing hypertension, as it helps to lower blood pressure by relaxing blood vessels and reducing blood volume Bezerra2022Sadoshima2002Lacourciére1995.
Interaction with Angiotensin-Converting Enzyme (ACE)
Recent studies have explored losartan's interaction with the angiotensin I-converting enzyme (ACE). Although losartan is not traditionally classified as an ACE inhibitor, it has been shown to interact with the sACE enzyme, potentially blocking its activity and intracellular signaling. This interaction may provide additional pathways through which losartan can exert its antihypertensive effects .
Anti-Inflammatory and Immunomodulatory Effects
Losartan also exhibits significant anti-inflammatory properties. It has been shown to reduce the expression of inflammatory cytokines such as interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) in various models, including chemotherapy-induced neuropathic pain and acute lung injury. These effects are mediated through the inhibition of inflammatory pathways in the dorsal root ganglia and respiratory conventional dendritic cells (cDCs), respectively Kim2019Liu2011.
Antioxidant Properties
In addition to its primary mechanism, losartan has been found to inhibit low-density lipoprotein (LDL) lipid peroxidation, which is a key factor in the development of atherosclerosis. By increasing the resistance of LDL to oxidative modification, losartan helps to reduce the formation of atherosclerotic lesions, thereby offering cardiovascular protection beyond blood pressure reduction .
Endothelial Function Improvement
Losartan improves endothelial function, particularly in patients with non-insulin-dependent diabetes mellitus (NIDDM). It enhances endothelium-dependent vasodilation, which is crucial for maintaining vascular health. This effect is likely mediated through the blockade of the AT1 receptor, which helps to preserve endothelial function .
Effects on Portal Hypertension
In cirrhotic rats with portal hypertension, losartan has been shown to decrease portal pressure and ameliorate hyperdynamic circulation. This effect is partly due to the suppression of the renin-angiotensin system and the reduction of aortic endothelial nitric oxide synthase (eNOS) protein expression, which collectively contribute to its therapeutic benefits in managing portal hypertension .
High-Dose Effects on Catecholamine Secretion
Interestingly, high doses of losartan can enhance catecholamine secretion from the adrenal gland. This effect is mediated by the activation of calcium influx through L-type calcium channels, suggesting that high-dose losartan may have complex and potentially adverse effects on catecholamine release, which could influence blood pressure regulation .
Antimetastatic Activity
Losartan has also been found to suppress the growth of pulmonary metastases by inhibiting CCR2 signaling and monocyte recruitment. This action is independent of its AT1 receptor antagonism and highlights losartan's potential role in cancer immunotherapy by disrupting the CCL2-CCR2 chemotactic axis .
Conclusion
Losartan's mechanism of action extends beyond its primary role as an AT1 receptor antagonist. It interacts with ACE, exhibits anti-inflammatory and antioxidant properties, improves endothelial function, and has unique effects on catecholamine secretion and cancer metastasis. These multifaceted actions make losartan a versatile therapeutic agent in the management of hypertension and other related conditions.
Sources and full results
Most relevant research papers on this topic